|
Drug Delivery Series: The Market for Transdermal and Transmucosal Drug Delivery Systems: Volume 4Published by: Kalorama Information Published: Jan. 1, 2002 - 100 Pages Order 2 or more reports in this series and save 25-40%! Call 800-298-5699Table of Contents Chapter 1: Executive Summary
Market Drivers Market Size and Growth Competitive and Market Analysis Chapter 2: Introduction and Overview
Scope and Methodology Reasons for Transdermal/Transmucosal Drug Delivery Systems History of Transdermal and Transmucosal Drug Delivery Phases of Drug Action Topical Drug Delivery Transdermal Patch Drug Delivery Electrotransport Drug Delivery Iontophoresis Transmucosal Drug Delivery Buccal Drug Delivery Vaginal Drug Delivery Chapter 3: Trends and Developments Adhesive Technology and Issues Adhesive Market Issues Biotechnological Issues Iontophoresis and Phonophoresis Developments in Insulin Delivery New Developments in Hormone Drug Delivery New Mucosal/Buccal Delivery Systems Other New Drug Delivery Systems Macroflux Technology Controlled Thermal Energy Technology New Ultrasound Technology Combination Delivery Technology Chapter 4: Market Size and Growth Chapter 5: Competitive Analysis Competitive Landscape Market Analysis Chapter 6: Company Profiles 3M Pharmaceuticals Alza Corporation Elan Corporation, plc Generex Biotechnology Corporation Genetronics Biomedical Corporation Labtec GmbH Lohmann Therapy-Systems Corp (LTS Lohmann Therapie Systeme AG) MacroChem Corporation Noven Pharmaceuticals, Inc. TheraTech, Inc. (Watson Laboratories, Utah) Chapter 7: Companies in Brief Altea Development Corp. Anteres Pharma, Inc. Atrix Laboratories, Inc. Biogel Technology, Inc. CeNeS Drug Delivery Ltd. SkyePharma Plc TransDermal Technologies, Inc. Vyteris Inc. Appendix: Company Directory List of Exhibits Table 2-1: Sequence of Drug Action Table 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Type, 1995-2005 Table 4-2: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Market Percent Share by Type, 1995-2005 Table 4-3: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems by Pharmaceutical and Drug Delivery Component, 1995-2005 Table 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005 Table 5-1: Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Revenues and Market Share by Supplier, 2000 Figure 4-1: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Revenues by Type, 1995-2005 Figure 4-2: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Share by Type, 2000 Figure 4-3: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Share by Type, 2005 Figure 4-4: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 1995-2005 Figure 4-5: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2000 Figure 4-6: The Worldwide Market for Transdermal/Transmucosal Drug Delivery Systems, Distribution of Revenue by Pharmaceutical and Drug Delivery Component, 2005 Figure 5-1: Worldwide Market for Pulmonary Drug Delivery Systems, Market Share by Leading Supplier, 2000 AbstractDrug Delivery Series: The Market for Transdermal and Transmucosal Drug Delivery Systems: Volume 4This volume will address transdermal and transmucosal drug delivery systems. Both of these systems continue to be of high interest for the delivery of proteins and peptides due to high permeability of mucosal tissue and adaptability of dermal application. |
|
|||
|
About MarketResearch.com
|
||||